Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
Inflammatory bowel disease (IBD) is chronic inflammation of the gastrointestinal tract (GIT) it includes two-condition Crohn’s disease (CD) and ulcerative colitis (UC) the prolonged inflammation may cause invasion of the multiple layers of the intestinal walls result in GIT damage. The current stud...
Saved in:
Main Authors: | Fadhel A. Abdullah, Maha A. Mahmood |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Medicine University of Baghdad
2024-12-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/2031 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study
by: Sumaiah J. Alarfaj, et al.
Published: (2025-01-01) -
Impact of liver transplantation on intestinal and systemic inflammation markers in patients with colitis ulcerosa concomitant with primary sclerosing cholangitis
by: Artur W. Uździcki, et al.
Published: (2024-12-01) -
Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01) -
Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
by: A. Yu. Baranovsky, et al.
Published: (2012-06-01) -
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres
by: David Young, et al.
Published: (2025-01-01)